Pricing Log in Create free account

Liminatus Pharma Inc. (LIMN) vs Traws Pharma, Inc. (TRAW)

Liminatus Pharma Inc. and Traws Pharma, Inc. are both Biotechnology companies. Liminatus Pharma Inc. and Traws Pharma, Inc. are of similar size ($3.5M and $3.4M). Across the 9 metrics below, Traws Pharma, Inc. leads on 5 and Liminatus Pharma Inc. on 4.

Valuation

Metric LIMN TRAW Biotechnology median
P/E n/m n/m 10.60
P/S n/m 1.28 9.40
P/B 8.05 2.16 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.06 0.66
EV/Sales n/m (0.48) 9.02
Earnings yield (940.00%) (656.52%) (32.88%)
Free cash flow yield (164.16%) (462.16%) (23.13%)

Profitability

Metric LIMN TRAW Biotechnology median
Gross margin — 100.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 294.43% (336.30%) (51.96%)
Return on assets (471.47%) (123.55%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric LIMN TRAW Biotechnology median
Revenue growth (TTM) — 1,159.29% 6.76%
EPS growth (last fiscal year) (112.19%) 102.33% 29.88%
Revenue growth, 5-year CAGR — 64.59% 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric LIMN TRAW Biotechnology median
Debt to equity 4.80 0.00 0.00
Current ratio 1.12 0.93 4.97
Net debt to EBITDA (0.37) 0.21 1.01

Dividend

Metric LIMN TRAW Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric LIMN TRAW Biotechnology median
Market cap 3.53m 3.38m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack